supernews.co.id Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–35
- Matches
- 35
- Sources here
- 13
- Companies here
- 5
Active search
35 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Tavia Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
Tavia Acquisition Corp. announced its earnings results for the second quarter and six months ended June 30, 2026. For the second quarter, the company reported a net loss of $0.400069 million, a decrease from a net income of $0.64582 million in the prior year. …
MetaVia Inc (MTVA) Earnings Forecast: Future EPS & Revenue Growth Estimates
MetaVia Inc (MTVA) has a price target of USD 15.50, with analysts forecasting a high of USD 21.00 and a low of USD 3.00. The company's EPS for the previous quarter was USD -0.79, exceeding the market expectation of USD -0.90, and the next …
MetaVia Inc. (NASDAQ: MTVA) Share Price, MTVA Stock News, MTVA Share Price & Updates
This page provides current stock information for MetaVia Inc. (NASDAQ: MTVA), including its stock price, daily range, and recent performance. It also lists several analyst recommendations and news updates related to the company's participation in investor forums and conferences. Financial data such as market …
MTVA: Q2 2026 saw clinical progress and a $5.3M net loss, with cash reserves at $12.6M
MTVA (MetaVia Inc.) reported significant clinical progress in Q2 2026 for its DA-1726 and vanoglipel programs, with Phase 1 data showing promising weight loss and liver outcomes. Despite a widened net loss of $5.3 million due to increased R&D, the company's cash reserves grew …
MetaVia Inc. Q2 2026: Net loss $5.3M, EPS $(0.90) — 10-Q Summary
MetaVia Inc. reported a net loss of $5.3 million for Q2 2026, with a diluted loss per share of $(0.90), showing an increase in net loss compared to the previous year but an improved EPS. The company also highlighted progress in its clinical pipeline, …
MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update
MetaVia Inc. announced its Q2 2026 financial results, highlighting progress in its clinical development programs for DA-1726 and vanoglipel. The company successfully reached the highest planned dose levels in its Phase 1 Part 3 study of DA-1726 for obesity, with 16-week topline data expected …
Form S-1 MetaVia Inc For: 29 July By Investing.com
This article announces the filing of Form S-1 by MetaVia Inc. on July 29. The brief report highlights this corporate action, possibly relating to an initial public offering or a new securities registration. The article provides only this essential information and is presented by …
Tavia Acquisition Corp. Revenue Breakdown – NASDAQ:TAVI
This page provides an overview of Tavia Acquisition Corp. (NASDAQ: TAVI) financials on TradingView, noting that the market is currently closed with no trades. It highlights the availability of fundamental data, including statements, statistics, dividends, earnings, and segment performance breakdowns by source and country. …
Tavia Acquisition Corp (TAVI) Cash Flow
This article provides the quarterly and annual cash flow statements for Tavia Acquisition Corp (TAVI), detailing operating, investing, and financing activities. It presents financial data from FY2024Q1 to FY2026Q1, including net income, changes in working capital, and cash balances. The article also includes FAQs …
MetaVia Inc (MTVA) Income Statement
This article provides the quarterly and annual income statements for MetaVia Inc (MTVA), detailing financial performance metrics such as operating expenses, R&D, depreciation, operating profit, and net income over several fiscal years and quarters. It also includes frequently asked questions about understanding the income …
MetaVia Inc (MTVA) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of MetaVia Inc (MTVA)'s dividend and stock split history. It notes that no dividends have been distributed in the past five years. The article details several stock merger events with 8:1 and 30:1 ratios that occurred in August 2023 …
Tavia Acquisition Corp (TAVI) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Tavia Acquisition Corp (TAVI), detailing its current support, resistance, indicators, and moving averages. It includes a summary of various technical indicators like MACD, RSI, and KDJ, alongside moving average signals. The analysis currently suggests a "Neutral" signal …
MetaVia Inc (MTVA) Institutional Confidence
This article provides details on the institutional confidence in MetaVia Inc (MTVA), listing key shareholders and their recent activity. Notable shareholders include Dong-A ST Co., Ltd., Citadel Advisors LLC, and individual investors like Kim (Hyung Heon) and Woodworth (Marshall H), with several showing significant …
MetaVia Inc (MTVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of MetaVia Inc (MTVA), detailing its support, resistance levels, and various technical indicators. It presents the stock's current market data, including its closing price and market cap, and evaluates its technical health through indicators like MACD, RSI, and …
MetaVia Inc (MTVA) Valuation: PE, PB & Fair Value Analysis
This article provides a brief valuation analysis for MetaVia Inc (MTVA), noting its current stock price and market capitalization. It highlights that key valuation metrics such as P/E, P/B, and P/CF ratios are currently undisclosed by the company. The article is part of TradingKey's …
MTVA Cash Flow Statement
This article provides the quarterly and annual cash flow statements for MetaVia Inc (MTVA), presenting detailed financial data related to operating, investing, and financing activities. It includes historical cash flow figures, year-over-year changes, and definitions for key cash flow metrics such as operating cash …
MTVA|MetaVia Inc|Price:1.430|Chg%:-0.060
This article provides a detailed financial summary for MetaVia Inc (MTVA), including its current stock price, market capitalization, and upcoming earnings date. It presents a comprehensive overview of the company's income statement, balance sheet, and cash flow statement, highlighting key financial indicators and year-over-year …
MTVA|MetaVia Inc|Price:1.480|Chg%:-0.030
This article provides a detailed financial summary for MetaVia Inc (MTVA), including its current stock price, market capitalization, and upcoming earnings date. It presents a comprehensive overview of the company's income statement, balance sheet, and cash flow statement, highlighting key financial indicators and year-over-year …
MetaVia Inc. Revenue Breakdown – NASDAQ:MTVA
This article provides a revenue breakdown for MetaVia Inc. (NASDAQ: MTVA) as part of its financial overview on TradingView. It indicates that further details on top segments and regional performance are available by source and country. The information is presented within the context of …
MetaVia completes dose titration in obesity drug trial By Investing.com
MetaVia Inc. announced that all patients in Part 3 of its Phase 1 clinical trial for the obesity treatment candidate DA-1726 have completed dose titration, reaching target doses of 48 mg and 64 mg. The trial evaluates the safety, tolerability, pharmacokinetics, and pharmacodynamics of …
Vita Inclinata to go public via merger with Tavia Acquisition, valued at $450M
Vita Inclinata Technologies is set to go public through a de-SPAC transaction with Tavia Acquisition Corp., valuing Vita at $450 million. This merger is intended to support Vita's growth plans, including a strategic acquisition in the defense and industrial sectors. The deal is expected …